





































Subtypes of Metabolic Syndrome and of Other Risk Factors
in Japanese Women With Erosive Esophagitis
Masahiro Sogabe, MD, PhD, Toshiya Okahisa, MD, PhD, Akira Yamanoi, MD, PhD,
and Tetsuji Takayama, MD, PhD
Abstract: Obesity and metabolic syndrome (MS) are strongly associ-
ated with erosive esophagitis (EE). The prevalence of MS and EE, and the
distribution of adipose tissue have been known to differ markedly between
men and women. Although the prevalence of EE in men with MS is known
to be higher in visceral fat type MS (V-type MS) than in subcutaneous fat
type MS (S-type MS), the association between EE and the types of MS in
women with MS is unclear. This study was a cross-sectional study
elucidating the association between EE and the types of MS in women
with MS.
Subjects were 454 women with MS who underwent a regular health
check-up. A distinction was made between V-type MS and S-type MS
and the prevalence of EE and the association between EE and other data
were elucidated.
Although there were some significant different factors in character-
istics between V-type MS and S-type MS, there was no significant diff-
erence in the prevalence of EE between V-type MS and S-type MS. The
presence of Helicobacter pylori (H. pylori) was significantly lower than in
subjects with EE (13.7%) than in subjects without EE (41.9%). The
frequency of hiatal hernia was significantly higher in subjects with EE
(60.8%) than in subjects without EE (24.6%). Logistic regression analysis
showed hiatal hernia (odds ratio: 4.673; 95% confidence interval: 2.448–
8.920; P< 0.001), hemoglobin A1c (HbA1c) (2.325; 1.110–4.870;
P< 0.05), and the presence of H. pylori (0.239; 0.101–0.567;
P< 0.005) were significant predictors of the prevalence of EE.
V-type MS may not be such an important factor for the prevalence of
EE in women with MS as in men with MS. The absence of H. pylori,
hiatal hernia, and HbA1c may be more important for the prevalence of EE
than the types of MS in women with MS.
(Medicine 93(28):e276)
Abbreviations: AFI = abdominal wall fat index, ALT = alanine
aminotransferase, AST = aspartate aminotransferase, BMI = body
mass index, CI = confidence interval, CT = computed tomography,
CV = coefficient of variation, DBP = diastolic blood pressure, EE =
erosive esophagitis, FPG = fasting plasma glucose, GERD =
gastroesophageal reflux disease, GGT = g-glutamyl transpeptidase,
H. pylori = Helicobacter pylori, HbA1c = hemoglobin A1c, HDL-C
= high-density lipoprotein cholesterol, IGT = impaired glucose
tolerance, LA = Los Angeles, LDL-C = low-density lipoprotein
cholesterol, LES = lower esophageal sphincter, MS = metabolic
syndrome, NGSP = National Glycohemoglobin Standardization
Program, NS = not significant, OR = odds ratio, P = preperitoneal fat
thickness, P = probability, S = subcutaneous fat thickness, SBP = sys-
tolic blood pressure, SD = standard deviation, S-type = subcutaneous
fat type, T-CHO = total cholesterol, TG = triglyceride, UA = uric
acid, V-type = visceral fat type, WC = waist circumference.
INTRODUCTION
T he prevalence of gastroesophageal reflux disease (GERD),including erosive esophagitis (EE), has been increasing in
both developed and developing countries, including Japan and
Western countries.1–3 Various conditions, such as obesity,
disturbance of the lower esophageal sphincter (LES), increase
in gastric acid production, increase in intragastric pressure, and
esophageal acid exposure, have been believed to play an import-
ant role in the development of GERD.4–9 The recent increase in
numbers of obese individuals with lifestyle-related diseases
associated with abnormalities in glucose metabolism and dysli-
pidemia, defined as metabolic syndrome (MS), has been alarm-
ing. Individuals with MS or visceral fat-dominant obesity are
known to be likely to exhibit GERD or EE.4,10–13 Additionally,
the prevalence of MS and EE was known to be higher in men than
in women.14–16 Although there have been several studies on the
association between MS and EE in the general population, there
have been few reports on the association between types of MS and
EE in the subjects with MS. The prevalence of EE in men with MS
is reported to be different between visceral fat type MS (V-type
MS) and subcutaneous fat type MS (S-type MS),17 but the
association between EE and the types of MS in women with
MS is unclear. Generally, subcutaneous and visceral fat-domi-
nant MS types are not distinguished on medical check-ups, and
individuals with both types of MS are treated in the same way. In
this study, we divided women with MS into those with V-type MS
and those with S-type MS by ultrasonography, and the association




Subjects were Japanese women with MS aged 30 to
85 years, who underwent a regular health check-up includ-
ing physical examinations, blood-test screening, upper gastro-
intestinal endoscopy, and abdominal ultrasonography at our
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hospital between April 2008 and March 2013. Most subjects
were asymptomatic, healthy adults residing around Takamatsu
city. Subjects who had a history of digestive tract surgery, who
took medications such as H2-receptor antagonist or proton
pump inhibitors, or who were diagnosed with gastric or eso-
phageal cancer at the time of upper gastrointestinal endoscopy
were excluded from this study. Body weight and height of the
subjects were determined, and body mass index (BMI) was
calculated. Waist circumference (WC) was measured at the
umbilical level. Venous blood samples were taken from all
subjects at around 09:00 hours following a 12-hours overnight
fast, and the levels of alanine aminotransferase (ALT), aspartate
aminotransferase (AST), g-glutamyl transpeptidase (GGT),
total cholesterol (T-CHO), triglyceride (TG), high-density lipo-
protein cholesterol (HDL-C), low-density lipoprotein choles-
terol (LDL-C), uric acid (UA), fasting plasma glucose (FPG),
and hemoglobin A1c (HbA1c) (National Glycohemoglobin
Standardization Program [NGSP]) were determined by com-
mon enzymatic methods using an auto analyzer (TBA-80FR;
Toshiba Medical System, Tokyo, Japan). Assessment for Heli-
cobacter pylori (H. pylori) infection was based on the detection
of the H. pylori-specific antibody in serum. H. pylori-specific
immunoglobulin G antibody titers were measured using the
direct ELISA kit (E Plate ‘‘Eiken’’ H. pylori antibody; Eiken
Kagaku, Tokyo, Japan). All subjects were informed that the
clinical data obtained by medical check-up may be retrospec-
tively analyzed, and informed consent was obtained. This study
was approved by the Ethics Committees of the Kagawa Pre-
fectural Cancer Detection Center.
Diagnosis of MS
The diagnostic criteria for MS adopted by the international
diabetes federation and the adult treatment panel III criteria are
used worldwide. We adopted the MS criteria proposed by the
international diabetes federation18 to take account of ethnic
specific values for WC. The MS criteria used in this study were
as follows: WC must exceed 80 cm for women, and 2 or more of
the following components must be present: (a) dyslipidemia: TG
at least 150 mg/dL and/or HDL-C less than 50 mg/dL, or medi-
cated for dyslipidemia; (b) hypertension: blood pressure at least
130/85 mm Hg or medicated for hypertension; and (c) impaired
glucose tolerance: FPG at least 100 mg/dL or medicated for
diabetes.
Upper Gastrointestinal Endoscopy
Standard endoscopic examination of the esophagus,
stomach, and duodenum was performed by endoscopy specialists
from the Gastroenterology Department of our hospital. All exa-
miners had more than 10 years of experience in endoscopy, and
were blinded to the results of the blood-test screening, physical,
and physiological examinations. Upper gastrointestinal endo-
scopy was performed using a conventional single-channel endo-
scope (GIF-H260, -PQ260, or -XP260; Olympus, Tokyo, Japan).
The severity of EE was graded was graded from A to D according
to the Los Angeles classification. We also considered a hiatal
hernia to be present if the gastroesophageal junction extended at
least 2 cm above the diaphragmatic hiatal impression during quit
inspiration. Endoscopic findings from each subject were finally
independently validated by a single endoscopy specialist.
Ultrasonography
Abdominal ultrasonography was performed in a morning
fasting state. A Xario SSA-660A instrument with a 3.5 MHz
convex-array probe (Toshiba Medical System) was used for
ultrasonography. We used the procedure reported by Suzuki
et al,19 because there were significant correlations between the
visceral fat area/the subcutaneous fat area ratio or visceral fat
area on computed tomography (CT) and the pre-peritoneal fat
thickness (P)/subcutaneous fat thickness (S) ratio or P observed
on ultrasonography in their report.19,20 Scanning was performed
at the optimal position, and the surface of the liver was kept
almost parallel to the skin by breath-holding. The subcutaneous
fat thickness was measured as the distance from the skin to the
linea alba. The pre-peritoneal fat thickness was measured as the
distance from the linea alba to the anterior surface of the liver
(peritoneum). The maximal pre-peritoneal fat thickness was
designated as P and subcutaneous fat thickness at the same time
point as S. The abdominal wall fat index (AFI), defined as the P/
S ratio, was calculated and AFI at least 1 and AFI less than 1
were considered as V-type MS and S-type MS, respectively. The
intra-individual reproducibility of sonographic measurements
[coefficient of variation (CV%)] was 8.8 3.1% for S,
6.6 2.3% for P, and 8.5 3.5% for AFI. The criteria of fatty
liver diagnosis by ultrasonography were as follows: the fatty
liver must have liver–kidney echo contrast and liver brightness,
as well as having deep attenuation and/or liver vessel blurring.21
Statistical Analysis
This study was a cross-sectional study elucidating the
association between EE and the types of MS in women with
MS. Data are expressed as means standard deviation (SD). A
probability (P) value of less than 0.05 was considered statisti-
cally significant. Comparison between 2 groups was performed
using the x2-test or Student’s t-test for independent samples. Pa
value was adjusted for confounding variables using analysis of
covariance. Age, BMI, WC, and the factors that P value was less
0.5 on univariate analysis were then subjected to a multivariate
logistic regression analysis. The covariates used for the multi-
variate analysis were age, BMI, WC, HDL, LDL, HbA1c,
alcohol consumption, H. pylori, and hiatal hernia. The odds
ratios and 95% confidence interval were analyzed for each
variable. All statistical analyses were performed using Med
Calc Software (Broekstraat, Mariakerke, Belgium).
RESULTS
Subject Description
Figure 1 shows the flow diagram of the enrolment of
subjects in this study. Of the 20,205 women who underwent
women who fulfilled the 
diagnostic criteria for MS
(n = 2606 women)
women who underwent 
a regular health check-up
(n = 20205 women)
women who did not fulfill the 
diagnostic criteria for MS
(n = 17599)
(between April 2008 and March 2013 at our hospital) 
women who underwent 
all necessary tests




(n = 454 women)
women who did no undergo all 
necessary tests




FIGURE 1. Flow diagram of the enrollment of subjects in this
study. MS¼metabolic syndrome.
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a regular health check-up between April 2008 and March 2013
at our hospital, 2606 women fulfilled the diagnostic criteria for
MS (data not shown). Of the 2606 subjects, 475 subjects
underwent physical examinations, blood-test screening, upper
gastrointestinal endoscopy, and abdominal ultrasonography. Of
the 475 subjects, 21 fulfilled the exclusion criteria and were
excluded, and the remaining 454 subjects were enrolled in this
study. Subject characteristics are shown in Table 1; mean age
was 58.3 8.1 years, mean BMI was 26.0 3.5 kg/m2, and
mean WC was 89.6 7.1 cm of all subjects. Of the 454 subjects
with MS, 50 (11.0%) and 404 (89.0%) had V-type MS or S-type
MS, respectively. The frequency of the positive of H. pylori in
all subjects was 38.8%. The frequency of hiatal hernia in all
subjects was 28.6%. The frequency of EE in all subjects was
11.2%. In the EE group, the distribution of Los Angeles grades
A, B, C, and D was 42, 9, 0, and 0 cases, respectively.
Comparison Between V-Type MS and S-Type MS
in Women With MS
Comparison of clinical characteristics in women with MS
between V-type MS and S-type MS is shown in Table 2, in
which the Pa value was adjusted for confounding variables,
including age, BMI, WC, alcohol consumption, and smoking
habit. HbA1c, TG, and UA were significantly higher in V-type
MS than in S-type MS. ALT, AST, GGT, and the frequency of
fatty liver were significantly higher in V-type MS than in S-type
MS. The frequency of hiatal hernia was significantly higher in
V-type MS than in S-type MS. In terms of the frequency of EE,
V-type MS and S-type MS had 12.0% and 11.1%, respectively.
There was no significant difference in the prevalence of EE
between V-type MS and S-type MS.
Comparison Between With and Without EE in
Women With MS
Comparison of clinical characteristics in women with MS
between with and without EE is shown in Table 3. The
frequency of the positive of H. pylori was significantly lower
in subjects with EE than in subjects without EE. The frequency
of hiatal hernia was significantly higher in subjects with EE than
in subjects without EE.
Predictors of EE
Univariate and multivariate independent predictors of EE
in women with MS are shown in Table 4. Of the 24 items related
to the clinical background of subjects with and without EE, the
presence of H. pylori and hiatal hernia were identified as
significant factors by univariate analysis. Multiple logistic
regression analysis was performed with age, BMI, WC, and
6 items that P value was less 0.5 by univariate analysis, such as
HDL-C, LDL-C, HbA1c, alcohol consumption, presence of H.
pylori, and hiatal hernia as covariates. Hiatal hernia, presence of
H. pylori, and HbA1c were significant and independent pre-
dictors of the prevalence of EE. The odds ratios (95% confi-
dence intervals, P value) for EE were as follows: hiatal hernia,
4.673 (2.448–8.920, P< 0.001), presence of H. pylori, 0.239
(0.101–0.567, P< 0.005), and HbA1c, 2.325 (1.110–4.870,
P< 0.05).
DISCUSSION
This study aimed to investigate whether there is a differ-
ence in the prevalence of EE between V-type MS and S-type
MS in Japanese women with MS. GERD and EE are particularly
likely to be associated with obesity and MS.4,10–13 Additionally,
the prevalence of GERD including EE and the distribution of
adipose tissue are known to be different between men and
women.10,11,14–16,22,23 Although there have been several studies
on the association between MS and EE in the general popu-
lation, there are few reports on the association between the types
of MS and EE in the subjects with MS. The prevalence of EE in
men with MS is reported to be higher in V-type MS than in S-
type MS,17 but there is no report on the association between EE
and the types of MS in women with MS. To our knowledge, this
study is the first to show that there is no significant difference in
the prevalence of EE between V-type MS and S-type MS and
the absence of H. pylori, hiatal hernia, and HbA1c are signifi-
cant predictors of the prevalence of EE in Japanese women
with MS.
In the majority of reports on MS, V-type MS and S-type
MS were regarded as MS, without making a distinction between
the types. Generally, subcutaneous and visceral fat-dominant
MS types are not distinguished on medical check-ups, and
individuals with both types of MS are treated in the same
way. MS is known to be associated with EE, and the visceral
TABLE 1. Subjects Characteristics
Number 454
Age (years) 58.3 8.1
BMI (kg/m2) 26.0 3.5
WC (cm) 89.6 7.1
SBP (mm Hg) 130.9 15.1
DBP (mm Hg) 77.8 9.2
Hypertension, n (%) 375 (82.6%)
T-CHO (mg/dL) 210.5 33.3
TG (mg/dL) 116.6 60.6
HDL-C (mg/dL) 60.8 14.3
LDL-C (mg/dL) 134.3 30.2
Dyslipidemia, n (%) 307 (67.6%)
UA (mg/dL) 4.9 1.1
FPG (mg/dL) 108.0 17.2
HbA1c (NGSP) (%) 6.1 0.7
IGT, n (%) 332 (73.1%)
ALT (IU/L) 27.7 18.9
AST (IU/L) 24.4 10.5
GGT (IU/L) 35.6 36.4
Fatty liver, n (%) 236 (52.0%)
V-type MS, n (%) 50 (11.0%)
Alcohol consumption, n (%) 140 (30.8%)
Smoking habit, n (%) 18 (4.0%)
Presence of Helicobacter pylori, n (%) 176 (38.8%)
Hiatal hernia, n (%) 130 (28.6%)
EE (þ/), n (%) 51 (11.2%)
LA classification (grade A/B/C/D) 42/9/0/0
Data are means standard deviation (SD).
ALT¼ alanine aminotransferase, AST¼ aspartate aminotransferase,
BMI¼ body mass index, DBP¼ diastolic blood pressure, EE¼ erosive
esophagitis, FPG¼ fasting plasma glucose, GGT¼ y-glutamyl trans-
peptidase, HbA1c¼ hemoglobin A1c, HDL-C¼ high density lipopro-
tein cholesterol, IGT¼ impaired glucose tolerance, LA¼Los Angeles,
LDL-C¼ low density lipoprotein cholesterol, MS¼metabolic syn-
drome, NGSP¼National Glycohemoglobin Standardization Program,
SBP¼ systolic blood pressure, T-CHO¼ total cholesterol, TG¼ trigly-
triglyceride, UA¼ uric acid, V-type¼ visceral type, WC¼waist cir-
cumference.
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fat predominance was reported to be associated with EE in men
with MS.17 However, we noticed that there might be no
significant difference in the prevalence of EE in women with
MS between V-type MS and S-type MS at medical check-up.
Thus, to elucidate differences between the types of MS, we
simply divided women with MS into those with V-type MS and
those with S-type MS. Although a making a distinction between
V-type MS and S-type MS by CT is the best method, radiation
exposure of CT is known as very danger for young women,
especially pregnancy women. Therefore, we selected the ultra-
sonography as a method for making a distinction between
V-type MS and S-type MS in women with MS.
A recent study demonstrated that hyperglycemia was a
significant risk factor of EE.24 The hyperinsulinism may have
promotion of visceral fat tissue and the hyperglycemia may
increase the esophageal acid exposure due to the anti-reflux
barrier mechanism through modulation of transient LES relax-
ation.25 In fact, the present study showed that HbA1c was
significantly higher in V-type MS than in S-type MS and
was one of the significant predictors of the prevalence of EE
in women with MS.
Although many studies have suggested that the risk for
developing GERD symptoms or EE increases with increasing
BMI,6 these associations have remained controversial.26–29
Obesity and abdominal visceral adipose tissue may increase
intra-abdominal pressure. BMI and WC are significantly
associated with intragastric pressure, gastroesophageal pressure
gradient, and separation of the gastroesophageal junction pres-
sure components.30,31 Visceral adipose tissue is a source of
inflammatory cytokines and is associated with systemic inflam-
mation in obese individuals.32,33Although visceral adipose
tissue rather than BMI and WC played a key role in driving
the association between MS and GERD in a previous study,34,35
there was no significant difference in women with MS in the
prevalence of EE between V-type MS and S-type MS in present
study. A recent study showed that visceral adipose tissue
volume was strongly associated with EE in both sexes.35
However, visceral adipose tissue volume was not associated
with EE in the highest group of visceral adipose tissue volume
in females.35 There may not be such a significant difference in
the visceral fat accumulation between V-type MS and S-type
MS in women with MS as there is between individuals with and
without MS. Therefore, there may be no significant difference
in the prevalence of EE in women with MS between V-type MS
and S-type MS in present study.
In some previous reports, H. pylori infection in patients
with EE was significantly less than in patients without EE,13 and
H. pylori serostatus has shown an inverse association with
GERD.36 This above mechanism may be cause of the generation
of ammonia, decreased acid production of gastric atrophy, and a
neuroimmunological influence.36 In present study, the fre-
quency of positive H. pylori infection in subjects with EE
TABLE 2. Comparison of Clinical Characteristics in Women With MS Between V-Type MS and S-Type MS
V-type MS (n¼ 50) S-type MS (n¼ 404) P value (Pa value)
Age (years) 54.9 8.9 58.7 8.0 <0.005
BMI (kg/m2) 27.1 4.0 25.8 3.5 <0.05
WC (cm) 92.2 7.6 89.3 6.9 <0.01
SBP (mm Hg) 129.6 14.1 131.1 15.2 (NS)
DBP (mm Hg) 78.5 8.5 77.7 9.3 (NS)
Hypertension, n (%) 37 (74.0%) 338 (83.7%) (NS)
T-CHO (mg/dL) 206.4 33.2 211.0 33.3 (NS)
TG (mg/dL) 139.3 63.0 113.8 59.8 (<0.05)
HDL-C (mg/dL) 56.7 11.9 61.3 14.5 (NS)
LDL-C (mg/dL) 132.1 29.0 134.5 30.3 (NS)
Dyslipidemia, n (%) 37 (74.0%) 270 (66.8%) (NS)
UA (mg/dL) 5.3 0.9 4.8 1.1 (<0.05)
FPG (mg/dL) 113.0 20.6 107.4 16.6 (NS)
HbA1c (NGSP) (%) 6.3 0.8 6.0 0.6 (<0.005)
IGT, n (%) 42 (84.0%) 290 (71.8%) (NS)
ALT (IU/L) 40.4 20.6 26.1 18.2 (<0.001)
AST (IU/L) 31.5 13.8 23.5 9.6 (<0.001)
GGT (IU/L) 50.3 45.2 33.8 34.8 (<0.005)
Fatty liver, n (%) 41 (82.0%) 195 (48.3%) (<0.001)
AFI 1.15 0.17 0.69 0.14 (<0.001)
Alcohol consumption, n (%) 15 (30.0%) 125 (30.9%) NS
Smoking habit, n (%) 3 (6.0%) 15 (3.7%) NS
Presence of Helicobacter pylori, n (%) 20 (40.0%) 156 (38.6%) (NS)
Hiatal hernia, n (%) 23 (46.0%) 107 (26.5%) (<0.005)
EE (þ/), n (%) 6 (12.0%) 45 (11.1%) (NS)
Data are meansSD. P value is based on the x2 test or Student’s t-test. Pa values within parentheses were adjusted for confounding variables.
AFI¼ abdominal wall fat index, ALT¼ alanine aminotransferase, AST¼ aspartate aminotransferase, BMI¼ body mass index, DBP¼ diastolic
blood pressure, EE¼ erosive esophagitis, FPG¼ fasting plasma glucose, GGT¼ y-glutamyl transpeptidase, HbA1c¼ hemoglobin A1c, HDL-
C¼ high density lipoprotein cholesterol, IGT¼ impaired glucose tolerance, LDL-C¼ low density lipoprotein cholesterol, MS¼metabolic syndrome,
NGSP¼National Glycohemoglobin Standardization Program, NS¼ not significant, SBP¼ systolic blood pressure, S-type¼ subcutaneous type,
T-CHO¼ total cholesterol, TG¼ triglyceride, UA¼ uric acid, V-type¼ visceral type, WC¼waist circumference.
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(13.7%) was significant lower than in subjects without EE
(41.9%), and the absence of H. pylori was one of the significant
predictors for EE. Thus, the result obtained from present study
was similar to previous studies.
The prevalence of the hiatal hernia was significantly higher
in subjects with EE than in subjects without EE, and the hiatal
hernia was a significant predictor of an increased prevalence of
EE. Additionally, the prevalences of the hiatal hernia, TG, ALT,
and fatty liver were significantly higher in V-type MS than in S-
type MS. Therefore, we surmise that subjects with V-type MS
may be more likely to develop EE than subjects with S-type MS,
similar to the development of non-alcoholic fatty liver disease
in subjects with MS.37 Dietary fat intake may reduce LES
pressure,38 and the presence of hiatal hernia and the increase
in upper abdominal pressure because of the visceral adipose,
may induce gastroesophageal reflux. However, present study
showed that there was no significant difference in the preva-
lence of EE in women with MS between V-type MS and S-type
MS. The discrepancy of the prevalence of EE between V-type
MS and S-type MS in gender may be related to the estrogen-
related sex hormones, which have protects on the mucosa in the
upper gastrointestinal tract.39,40 Interestingly, our previous
study showed that the prevalence of EE in V-type MS in
men with MS was 28.3%.17 On the other hand, the present
study showed that the prevalence of EE in V-type MS in women
with MS was 12.0%. There was a significant difference in the
prevalence of EE in V-type MS between men and women.
Therefore, although V-type MS was one of the most significant
predictors of an increased prevalence of EE in men with MS, V-
type MS may not be a predictor of the prevalence of EE in
women with MS.
There were several limitations to the present study. First,
we would not fully evaluate the cause-and-effect relationship
between EE and women with MS because the present study was
a cross-sectional study design. Second, levels of estrogen-
related sex hormones and adipocytokines were not measured,
and the physical activity and the state of menses were not
investigated. Third, the numbers of the female subjects fulfilled
the diagnostic criteria for MS and EE was very small in the
present study. Fourth, most 2606 women who had MS
(Figure 1) did not undergo upper gastrointestinal endoscopy
in the present study, because the Japanese who undergo a
medical check-up tend to select upper gastrointestinal series
than upper gastrointestinal endoscopy for the assessment of
upper gastrointestine. However, there was no significant differ-
ence in the characteristics between women with MS who
underwent upper gastrointestinal series and women with MS
who underwent upper gastrointestinal endoscopy (data not
shown). Fifth, there was a possibility of selection bias because
most of the participants in the present study were healthy
individuals who hoped to undergo a medical check-up in
Ningen Dock.
In conclusion, the present study showed that there was no
significant difference in women with MS in the prevalence of
EE between V-type MS and S-type MS. In addition, the hiatal
hernia and HbA1c were significant factors of an increased
TABLE 3. Comparison of Clinical Characteristics in Women With MS Between With and Without EE
EE (þ) (n¼ 51) EE () (n¼ 403) P value
Age (years) 59.1 8.4 58.2 8.1 NS
BMI (kg/m2) 26.2 4.4 26.0 3.5 NS
WC (cm) 89.3 7.1 89.7 7.1 NS
SBP (mm Hg) 129.9 16.1 131.0 15.0 NS
DBP (mm Hg) 75.8 9.3 78.0 9.2 NS
Hypertension, n (%) 42 (82.4%) 333 (82.6%) NS
T-CHO (mg/dL) 204.5 32.7 211.3 33.4 NS
TG (mg/dL) 107.6 52.9 117.8 61.4 NS
HDL-C (mg/dL) 61.6 12.9 60.7 14.5 NS
LDL-C (mg/dL) 128.3 30.1 135.0 30.1 NS
Dyslipidemia, n (%) 33 (64.7%) 274 (68.0%) NS
UA (mg/dL) 4.8 1.0 4.9 1.1 NS
FPG (mg/dL) 111.5 21.8 107.6 16.5 NS
HbA1c (NGSP) (%) 6.2 0.7 6.1 0.7 NS
IGT, n (%) 38 (74.5%) 294 (73.0%) NS
ALT (IU/L) 31.2 29.3 27.2 17.2 NS
AST (IU/L) 26.5 15.7 24.2 9.6 NS
GGT (IU/L) 32.3 23.5 36.0 37.7 NS
V-type MS, n (%) 6 (11.8%) 44 (10.9%) NS
Fatty liver, n (%) 28 (54.9%) 208 (51.6%) NS
Alcohol consumption, n (%) 19 (37.3%) 121 (30.0%) NS
Smoking habits, n (%) 1 (2.0%) 17 (4.2%) NS
Presence of Helicobacter pylori, n (%) 7 (13.7%) 169 (41.9%) <0.001
Hiatal hernia, n (%) 31 (60.8%) 99 (24.6%) <0.001
Data are meansSD. P value is based on the x2 test or Student’s t test.
ALT¼ alanine aminotransferase, AST¼ aspartate aminotransferase, BMI¼ body mass index, DBP¼ diastolic blood pressure, EE¼ erosive
esophagitis, FPG¼ fasting plasma glucose, GGT¼ y-glutamyl transpeptidase, HbA1c¼ hemoglobin A1c, HDL-C¼ high-density lipoprotein
cholesterol, IGT¼ impaired glucose tolerance, LDL-C¼ low-density lipoprotein cholesterol, MS¼metabolic syndrome, NGSP¼National Glyco-
hemoglobin Standardization Program, NS¼ not significant, SBP¼ systolic blood pressure, T-CHO¼ total cholesterol, TG¼ triglyceride, UA¼ uric
acid, V-type¼ visceral type, WC¼waist circumference.
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prevalence of EE, and the presence of H. pylori was a significant
factor of a decreased prevalence of EE in women with MS.
We suggest that the hiatal hernia, HbA1c and the absence of
H. pylori may be more important factors for the prevalence
of EE than the types of MS in Japanese women with MS.
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